Artificial Valve Endocarditis Reduction Trial

NATerminatedINTERVENTIONAL
Enrollment

807

Participants

Timeline

Start Date

July 31, 1998

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Aortic Valve DiseaseMitral Valve DiseaseEndocarditis
Interventions
DEVICE

Artificial Mechanical Heart Valve

Both arms used market released mechanical heart valves in accordance with approved labeling

Trial Locations (16)

32803

Florida Heart Group, Orlando

55902

Mayo Clinic, Rochester

77030

Texas Heart Institute, Houston

84103

LDS Hospital, Salt Lake City

97225

Sisters of Providence Health System, Portland

02114

Massachusetts General Hospital, Boston

02115

Brigham and Womens Hospital, Boston

Unknown

University of Alberta Hospital, Edmonton

University of British Columbia, Vancouver

Hôpital G. Et R. Laënnec, Nantes

Deutches Herzzentrum Berlin, Berlin

Fond Ne Centro S. Raffaele, Milan

St. Antonius Ziekenhuis, Nieuwegein

Hospital 12 de Octubre, Madrid

Hopital Regional-Service de Cardiologie, Sion

CH-3010

Inselspital, Bern

Sponsors
All Listed Sponsors
collaborator

University of Pittsburgh

OTHER

lead

Abbott Medical Devices

INDUSTRY